Rauscher and Fairweather-Tait compared the fractional absorption (FA) of zinc using a double isotope tracer method (Friel et al, 1992) to that estimated from the fecal monitoring method in their recent publication,`Can a double isotope method be used to measure fractional zinc absorption from urinary samples?' . We agree with Rauscher & Fairweather-Tait that there is a need for a simple method to measure zinc FA, and the double isotope tracer method is an attractive alternative to fecal monitoring because of the simplicity of the method and minimal requirement for subject compliance. Rauscher & Fairweather-Tait concluded that the double isotope tracer method does not reliably predict zinc FA because it yields values for FA which are different from those obtained using fecal monitoring. Based on a number of theoretical and experimental problems associated with implementation of the fecal monitoring technique for determining zinc FA, we disagree with this conclusion. Such problems are minimized in the double isotope tracer technique.
Some of the theoretical problems associated with the fecal monitoring method for determination of what Rauscher & Fairweather-Tait called apparent absorption were pointed out by Wastney & Henkin (1989) . These investigators showed that estimates of zinc FA obtained from fecal monitoring are variable because such measurements represent a combination of the processes of absorption, endogenous secretion and fecal elimination. Attempts proposed by English et al (1989) and to correct estimates of apparent absorption obtained by fecal monitoring for re-secretion of absorbed zinc are at best, approximations. In fact, the only way to make this correction accurately requires a sophisticated kinetic analysis of the responses in plasma and feces for both oral and intravenously administered tracers using a detailed compartmental model.
Even if a correction could be developed for re-secretion of absorbed zinc, experimental problems associated with the fecal monitoring technique remain daunting. As stated by the authors in their introduction, the fecal monitoring method is`prone to errors associated with incomplete recovery.' In fact, comparisons of the two methods could not be made in one-third of their subjects because fecal collections were incomplete. If it is obvious that samples were incomplete in one-third of the subjects, is it not possible that fecal collections were relatively incomplete for the other subjects as well? Based on the data provided in their paper, there is strong evidence that the fecal collections were incomplete. For the remaining ten subjects, the estimated zinc FA from the fecal monitoring data was higher than that from the double isotope data in eight persons (range of difference: 37±83%). Incomplete collections resulting from either loss of sample by the subject or termination of the metabolic collection before all of the unabsorbed isotope has traversed through the gut will lead to an overestimate of zinc FA.
In contrast, the theoretical and experimental problems associated with the double isotope tracer method are relatively modest. A rigorous mathematical justi®cation of this technique for determining zinc FA is beyond the scope of this letter, but a brief summary is given here. Since most of plasma zinc equilibrates with multiple extraplasma zinc pools quickly, the kinetic behavior in plasma of intravenous injected zinc tracer exhibits a slowly declining monoexponential pattern after a couple of days. Tracer given orally has the same appearance in plasma after ®rst pass absorption is complete since the fraction of orally administered tracer that is absorbed into the plasma equilibrates with extraplasma zinc pools and routes of renal and gastrointestinal losses in the same manner as intravenously administered tracer. It can be shown that the plasma ratio of the orally administered tracer to that administered IV (assuming unit doses of each) measured at any time after the two tracer responses become roughly parallel on a semilogarithmic plot, provides a measure of zinc FA. This same ratio of oral to IV tracers in the urine can also be used to determine the FA of zinc because the fractional rates of urinary excretion of the two zinc tracers are identical.
We developed a detailed compartmental model based on plasma, urine and fecal tracer data obtained from six normal women following simultaneous administration of oral and IV stable isotope tracers . Using a theoretical data set simulated from the model, we found that the double isotopic tracer estimation of FA closely approximated that of the model. A single sampling of the tracer ratio in the plasma or a 24 h urine collection on the third day following isotope administration yielded values of FA that were only 5% higher than the reference value simulated from the model. Moreover, the same approximation was provided by the tracer ratio from a spot urine sample simulated in the model on the morning of the fourth day. The approximation of the double isotope tracer method to the reference value improved asymptotically as the tracer ratio was obtained with increasing time after tracer administration. Using the same theoretical data set, the fecal monitoring technique employing the English (English et al, 1989) correction for re-secretion of absorbed zinc compared poorly to the reference value from the model. During the ®rst ten days after tracer administration, the fecal monitoring technique yielded signi®cant overestimates of FA; beyond twelve days the technique signi®cantly and progressively underestimated FA.
We obtained similar results when`real' data from each of the six women in the study were analyzed. Zinc FA values estimated by the fecal monitoring and double isotope tracer methods were compared to the reference value determined from the model ®tted to all of the tracer and tracee data obtained from that individual. These data included daily measurements of each tracer in plasma and urine for 6 d and in feces for 12 d as well as zinc tracee measurements in total urine and feces for the respective time periods. The double isotope tracer method yielded values averaging about 7% higher than the reference value for FA; those derived from the fecal monitoring technique averaged about 24% higher.
In summary, we agree with Rauscher & FairweatherTait that the double isotope tracer method for measuring the FA of zinc needs to be validated. However, because of the inherent¯aws in the fecal monitoring method, it cannot be used as the`gold standard.' Comparing both methods against the results from a detailed compartmental model ®tted to the same data showed that the double isotope tracer method is a more accurate measure of zinc FA than is the fecal monitoring method, and it requires minimal subject compliance. We believe the double isotope tracer method is the current method of choice. 
JC King

Reply to letter from King et al
We agree with many of the points made by King et al, in particular the many dif®culties associated with the faecal monitoring technique, and are at present addressing some of the problems by evaluating the use of rare earth elements as non-absorbable faecal markers for copper, an element similar to zinc in that endogenous secretions make a signi®cant contribution towards faecal losses. Rare earth elements follow a similar excretory pattern to unabsorbed stable isotopes of iron and, by inference, other inorganic nutrients like zinc (Schuette et al, 1993) .
The criticisms levied at us regarding the accuracy of absorption results calculated from faecal monitoring are well-recognised by people working in the ®eld of mineral metabolism. For the purposes of this paper our intention was to examine the validity of the double isotope technique using results generated from a study on non-insulin dependent diabetes . As such, the study was not designed to test the double isotope technique per se but was an adventitious use of data produced for other purposes. King et al have an advantage over us in that they speci®cally designed a study to test the double isotope technique, the results of which have recently been published . They found that zinc absorption calculated from faecal collections was underestimated. Whilst this may well be the case with faecal monitoring, it does not invalidate the observation in our paper that the estimation of true zinc absorption from isotope enrichment in urine was inconsistent from day to day. Our conclusion from these ®ndings is that the method is unreliable.
The dif®culties that surround the double isotope technique when used to measure zinc absorption are somewhat different to those for calcium, the element for which the method was originally developed (Yergey et al, 1987) . Sample contamination with zinc, a frequent problem, must be avoided, therefore the method can only be performed in the hands of experts who are used to dealing with trace element analysis. This in itself limits the application of the method. The doses of zinc isotope must be high enough to produce urine that is adequately enriched after a long enough equilibration time, suggested by Friel et al (1992) to be 40 h, but not too high to perturb normal zinc metabolism. Measuring urine samples of low zinc concentration with a low isotope enrichment is technically exacting. Another constraint is the need to administer a zinc isotope intravenously, a procedure that is not always acceptable. For these reasons, we are not yet convinced that the double isotope technique is an acceptable technique and suggest that faecal monitoring, preferably incorporating further methodological improvements, remains a more suitable method for obtaining information on zinc absorption.
